On Tuesday, 26 January 2021, Allen&Overy (Belgium) LLP hosted a webinar on the key developments in parallel trade of pharmaceuticals in 2020. In this blog post, we discuss a few key topics and ...

At the core of the definition, a Parallel import is a non-counterfeit product imported from another country without the permission of the intellectual property owner. They are also goods that are not ...

Stephen Pollard claims absurdly that parallel trade in medicines is life threatening ("There Is No Such Thing as a Free Drug," editorial page, 2 July). Yet his flawed report contains no substantiation ...

In 2021, the European Union opened up a formal investigation into Mondelēz International for allegedly restricting parallel trade. What is parallel trade? And how can it harm competition? In 2021, the ...

LONDON, May 14 (Reuters) - Pfizer Inc. , the world's largest drugmaker, locked horns with European drug wholesalers on Monday, accusing companies engaged in so-called "parallel trade" of fuelling ...

The shipment of bona fide pharmaceutical drugs into Britain from Europe may cost the UK pharmaceutical industry more than £770million a year. The net effect on the UK economy as a whole, taking into ...

Consumer groups argue that parallel trading leads to cheaper prices but trade mark owners say it jeopardizes their long-term relationships with both distributors and consumers. Peter Hallett of ...

Parallel trade may be a bane for drug supplies in low-cost countries, but it's been a boon for Andreas Mohringer and his company, EurimPharm Arzneimittel. As Bloomberg reports, Mohringer has made a ...

Imposing trade restrictions on parallel imports has the surprising effect of motivating a firm to export, according to a new study using game theory economic analysis. Economists Santanu Roy, Southern ...

Executing Primary Parallel trades will improve trading strategies leaps and bounds. Secondary and Tertiary Parallel Trades evolve and identifying the new correlations will fatten your profits.

The fiscal mess in Greece has been hard enough on drugmakers, not to mention drug supplies for patients. But the government's attempts to budget-cut its way into a solution has put an even bigger kink ...